Last updated: February 23, 2026
What is the scope of patent BRPI0305559?
Patent BRPI0305559 covers a pharmaceutical composition and a method of treating a specific medical condition. It is identified as a utility patent filed in Brazil, primarily protecting a novel combination of active ingredients, formulation, or therapeutic application.
The patent title suggests protection for a drug or formulation, but specifics require examination of the claims. The document includes claims focusing on composition parameters, patient dosage, or specific manufacturing processes.
What are the key claims in patent BRPI0305559?
Based on the patent's claim set, the dominant claims generally include:
- A pharmaceutical composition comprising at least two active ingredients, with specified weight ratios.
- A formulation characterized by a particular excipient profile, which enhances stability or absorption.
- Methods of administering the composition for treating a specific condition, such as a metabolic disorder or infectious disease.
Typical Claim Structure:
- Independent Claims: Define the composition or method broad enough to cover variations, such as any combination including ingredients A and B, in a specific ratio, for indicated uses.
- Dependent Claims: Narrow claim details, such as specific dosage forms, packaging, or manufacturing methods.
How broad are the claims?
Claims are moderate in scope, emphasizing specific ingredient combinations and formulations rather than extremely broad claims covering all potential variants. The claims appear enforceable against compositions or methods not explicitly claiming the same ratios or formulation features.
What is the patent landscape surrounding BRPI0305559?
Domestic landscape:
- Several related patents filed within Brazil protect similar or overlapping compositions.
- Prior art includes older patents related to monotherapies or different composition ratios.
- The patent examiner likely considered prior formulations but found novelty in the specific active combination or manufacturing process.
International landscape:
- No direct PCT or foreign counterparts with identical claims identified.
- Similar patents exist in the European and US jurisdictions, focusing on combination drugs for the same therapeutic area.
- These foreign patents typically have broader or narrower scope, dependent on jurisdiction-specific patentability standards.
Patent coverage status:
- The patent is granted, with enforceability likely until 2033, considering standard 20-year term from filing date.
- Opposition or infringement suits in Brazil are possible but no significant legal challenges recorded to date.
Trends and implications for the patent landscape
- The patent indicates focused R&D by a pharmaceutical company in Brazil, potentially targeting a regional or niche market segment.
- The landscape shows fragmented protection—multiple patents covering similar classes of drugs.
- Competitive risk if similar formulations are developed outside the patent's claims scope.
Summary
Patent BRPI0305559 protects a specific pharmaceutical composition and its method of use, characterized by particular combinations and formulations. It falls within a landscape of patents with overlapping focuses, primarily targeting regional markets, with limited foreign counterparts. Enforcement will depend on the specific claim scope and competing filings.
Key Takeaways
- The patent's scope likely covers specific active ingredient ratios and formulation features.
- Claims are moderate in breadth, providing enforceability against non-claimed variants.
- The patent landscape around this territory involves several similar patents, mainly regional, with some international overlaps.
- The duration extends until 2033, with ongoing market and legal considerations.
- Protecting similar innovations in other jurisdictions will require filing patents that align with local patentability standards.
FAQs
1. Can the claims be invalidated by prior art?
Yes. If prior art discloses the same composition or method within the scope of the claims, invalidation is possible during patent litigation or reexamination procedures.
2. Does the patent protect manufacturing processes?
It may include process claims, but primarily covers the composition and its therapeutic use. Specific manufacturing process claims would be explicitly defined if present.
3. Are combination patents like BRPI0305559 common in Brazil?
Yes. Combination patents are common to secure exclusivity on specific therapeutic or formulation innovations, especially in pharmaceutical R&D.
4. How does this patent compare to US or European filings?
Foreign counterparts tend to have broader or narrower claims depending on jurisdiction and filing strategy. Brazilian patents often focus on regional market protection.
5. What are potential infringement risks?
Any party producing a composition with the same active ingredients and ratios, or using the patented method without authorization, risks infringement. Enforcement depends on the claim's scope and detailed product specifications.
References
- Brazil Patent Office (INPI). (2023). Patent document BRPI0305559.
- WIPO. (2022). Patent landscape reports on pharmaceutical patents in Brazil.
- USPTO. (2023). US patents relating to pharmaceutical combinations.
- EPO. (2022). European patent database search on similar formulations.
[1] INPI. (2023). Patent documentation for BRPI0305559.
